NanoViricides, Inc.NNVCNYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank27
3Y CAGR-10.6%
5Y CAGR-5.7%
Year-over-Year Change
Research and development spending
3Y CAGR
-10.6%/yr
vs +1.9%/yr prior
5Y CAGR
-5.7%/yr
Recent deceleration
Acceleration
-12.5pp
Decelerating
Percentile
P27
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $4.57M | -17.6% |
| 2025 | $5.55M | +2.1% |
| 2024 | $5.44M | -14.9% |
| 2023 | $6.39M | +10.5% |
| 2022 | $5.78M | -5.4% |
| 2021 | $6.11M | +30.2% |
| 2020 | $4.70M | -20.7% |
| 2019 | $5.92M | +22.7% |
| 2018 | $4.83M | -12.7% |
| 2017 | $5.53M | - |